Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The serotonergic system in Parkinson's disease
Philippe Huot, Susan H. Fox, Jonathan M. Brotchie
Progress in Neurobiology (2011) Vol. 95, Iss. 2, pp. 163-212
Closed Access | Times Cited: 182

Showing 1-25 of 182 citing articles:

Olfactory dysfunction in Parkinson disease
Richard L. Doty
Nature Reviews Neurology (2012) Vol. 8, Iss. 6, pp. 329-339
Closed Access | Times Cited: 634
Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.
George DeMaagd, Ashok Philip
PubMed (2015) Vol. 40, Iss. 8, pp. 504-32
Closed Access | Times Cited: 500
A Whole-Brain Atlas of Inputs to Serotonergic Neurons of the Dorsal and Median Raphe Nuclei
Iskra Pollak Dorocic, Daniel Fürth, Yang Xuan, et al.
Neuron (2014) Vol. 83, Iss. 3, pp. 663-678
Open Access | Times Cited: 423
Olfaction in Parkinson's disease and related disorders
Richard L. Doty
Neurobiology of Disease (2011) Vol. 46, Iss. 3, pp. 527-552
Open Access | Times Cited: 397
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease
Philippe Huot, Tom H. Johnston, James B. Koprich, et al.
Pharmacological Reviews (2013) Vol. 65, Iss. 1, pp. 171-222
Closed Access | Times Cited: 315
Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease
Yunqi Xu, Junqiang Yan, Peng Zhou, et al.
Progress in Neurobiology (2012) Vol. 97, Iss. 1, pp. 1-13
Open Access | Times Cited: 278
Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
Lars Brichta, Paul Greengard, Marc Flajolet
Trends in Neurosciences (2013) Vol. 36, Iss. 9, pp. 543-554
Closed Access | Times Cited: 204
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications
M. Angela Cenci
Frontiers in Neurology (2014) Vol. 5
Open Access | Times Cited: 202
Molecular and anatomical organization of the dorsal raphe nucleus
Kee Wui Huang, Nicole Ochandarena, Adrienne C. Philson, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 195
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 115-128
Closed Access | Times Cited: 157
An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases
Boon Chin Heng, Dominique Aubel, Martin Fussenegger
Biotechnology Advances (2013) Vol. 31, Iss. 8, pp. 1676-1694
Closed Access | Times Cited: 181
Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
Lorraine V. Kalia, Jonathan M. Brotchie, Susan H. Fox
Movement Disorders (2012) Vol. 28, Iss. 2, pp. 131-144
Closed Access | Times Cited: 112
Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry
Philippe De Deurwaerdère, Giuseppe Di Giovanni, Mark J. Millan
Progress in Neurobiology (2016) Vol. 151, pp. 57-100
Closed Access | Times Cited: 111
Core, social and moral disgust are bounded: A review on behavioral and neural bases of repugnance in clinical disorders
Carmelo M. Vicario, Robert D. Rafal, Davide Martino, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 80, pp. 185-200
Closed Access | Times Cited: 99
Serotonergic system, cognition, and BPSD in Alzheimer’s disease
Saikat Chakraborty, Jack C. Lennon, Sridhar A. Malkaram, et al.
Neuroscience Letters (2019) Vol. 704, pp. 36-44
Open Access | Times Cited: 97
Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease
Sebastian Schmidt, Malte D. Luecken, Dietrich Trümbach, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Modeling dyskinesia in animal models of Parkinson disease
Nicolas Morin, Vincent A. Jourdain, Thérèse Di Paolo
Experimental Neurology (2013) Vol. 256, pp. 105-116
Closed Access | Times Cited: 95
Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine
José R. Santos, João Antônio Cunha, Aline Lima Dierschnabel, et al.
Behavioural Brain Research (2013) Vol. 253, pp. 68-77
Closed Access | Times Cited: 86
Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin
Ronise Martins Santiago, Janaína K. Barbiero, Raisa W. Gradowski, et al.
Behavioural Brain Research (2013) Vol. 259, pp. 70-77
Closed Access | Times Cited: 74
Serotonergic Regulation of Excitability of Principal Cells of the Dorsal Cochlear Nucleus
Zheng‐Quan Tang, Laurence O. Trussell
Journal of Neuroscience (2015) Vol. 35, Iss. 11, pp. 4540-4551
Open Access | Times Cited: 72
Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson's disease are associated with nonmotor symptoms
Qing Tong, Li Zhang, Yongsheng Yuan, et al.
Parkinsonism & Related Disorders (2015) Vol. 21, Iss. 8, pp. 882-887
Closed Access | Times Cited: 68
Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson’s Disease and Adverse Effects of L-DOPA
Ana Muñoz, Andrea López-López, Carmen M. Labandeira, et al.
Frontiers in Neuroanatomy (2020) Vol. 14
Open Access | Times Cited: 53
Mass spectrometry imaging identifies abnormally elevated brain l -DOPA levels and extrastriatal monoaminergic dysregulation in l -DOPA–induced dyskinesia
Elva Fridjonsdottir, Mohammadreza Shariatgorji, Anna Nilsson, et al.
Science Advances (2021) Vol. 7, Iss. 2
Open Access | Times Cited: 42
The serotonergic system in motor and non-motor manifestations of Parkinson’s disease
Philippe Huot, Susan H. Fox
Experimental Brain Research (2013) Vol. 230, Iss. 4, pp. 463-476
Closed Access | Times Cited: 69
The pathomechanisms underlying Parkinson's disease
K. A. Jellinger
Expert Review of Neurotherapeutics (2014) Vol. 14, Iss. 2, pp. 199-215
Closed Access | Times Cited: 66
Page 1 - Next Page

Scroll to top